ClinicalTrials.Veeva

Menu

Digestive Colonisation by Highly Resistant Bacteria (CODBAHRE)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Risk Factor

Study type

Observational

Funder types

Other

Identifiers

NCT04085380
CODBAHRE
2019-A01226-51 (Other Identifier)
APHP180561 (Other Identifier)

Details and patient eligibility

About

The aim of this study is to identify in hospitalized patients, the risk factors associated with the digestive colonisation by emergent extensively drug-resistant bacteria (eXDR), to optimize their detection and the medical care for carriers these patients

Full description

CODBAHRE is a french, regional study, involving 9 centers. Recruitment will take place in all the departments of the centers involved under the supervision of the Infection Control Team.

All patients hospitalized more than 24 hours, on a given day are eligible for the protocol, except the patients unable to answer the questionnaire.

After collecting the non-opposition of the patient, patients will be screened by rectal swab and a questionnaire will be completed.

Each sample will be analyzed to detect eXDR carrying patients.

The carrying patients will be followed during 6 months to estimate the proportion of the population which developped a bacterial infection. This information will be collected by a retrospective telephone survey of carrying patients.

Enrollment

2,396 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hospitalization of more than 24 hours
  • Give his no objection

Exclusion criteria

  • Hospitalization in psychiatry
  • Unwilling to participate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems